# Corvus Pharmaceuticals, Inc.: Form 8-K, filed Mar 13, 2026

- Company: [Corvus Pharmaceuticals, Inc.](/companies/crvs.md) (CIK 1626971)
- Form: 8-K
- Filed: 2026-03-13
- Accepted by EDGAR: Mar 13, 2026, 08:46 ET
- Period: 2026-03-13
- Accession: 0001104659-26-027390
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1626971/000110465926027390/tm268518d4_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1626971/000110465926027390/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1626971/000110465926027390/tm268518d4_8k.htm

Filed Mar 13, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-027390. Last ingested by Listed: Nov 15, 2026, 00:49 ET. No prices; not investment advice.
